SCHEMBL1134308

SCHEMBL1134308

O=Cc1ccc(Oc2cccc(OCc3ccccc3)c2)cc1Br

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 8/20 0.56
▸ MAOA P21397 3/20 0.56
▸ ERN1 O75460 1/20 0.49
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ CCNB2 O95067 1/20 0.48
▸ CDK1 P06493 1/20 0.48
▸ CDK4 P11802 1/20 0.48
▸ CCNB1 P14635 1/20 0.48
▸ CCND1 P24385 1/20 0.48
▸ CCNB3 Q8WWL7 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ LCK P06239 1/20 0.47
▸ BCHE P06276 1/20 0.47
▸ NR4A2 P43354 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ IP6K1 Q92551 1/20 0.45
▸ SMPD1 P17405 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14117442 0.92 MAOB (0.56) MAOBMAOAERN1NPC1RAB9A
SCHEMBL3122711 0.84 MAOB (0.56) MAOBMAOAERN1NPC1RAB9A
SCHEMBL1564068 0.84 MAOB (0.56) MAOBMAOAERN1NPC1RAB9A
SCHEMBL1134249 0.83 LMNA (0.50) MAOBMAOAERN1NPC1RAB9A
SCHEMBL13035521 0.81 MAOB (0.44) MAOBMAOAERN1NPC1RAB9A
SCHEMBL1883702 0.81 MAOB (0.70) MAOBMAOANPC1RAB9ACCNB2
SCHEMBL1588758 0.80 BACE1 (0.57) MAOBMAOANPC1RAB9ACCNB2
SCHEMBL13127068 0.80 LTA4H (0.46) ERN1SMPD1
SCHEMBL3445766 0.80 MAOB (0.43) MAOBMAOAERN1NPC1RAB9A
SCHEMBL28237963 0.80 MAOB (0.72) MAOBMAOACCNB2CDK1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285384-A2 BORON-CONTAINING SMALL MOLECULES Anacor Pharmaceuticals, Inc. (US) 2011-02-23 — — EP disclosed
US-20100256092-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2010-10-07 — — US disclosed
US-20100256092-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2010-10-07 — — US disclosed
WO-2009140309-A2 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2009-11-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256092-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, BCL6, BTD MAOB 301/4885MAOA 2465/4885ERN1 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback